Simon N.R. Harford insider trades
Open-market stock purchases and sales by Simon N.R. Harford, Chief Financial Officer at Amicus Therapeutics, Inc, from SEC Form 4 filings since May 9, 2017.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $2.1M |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $2.4M |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $1.4M |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $1.4M |
| Dec 26, 2025 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $1M |